152 related articles for article (PubMed ID: 12483967)
21. Transitory macrophage activation in the granulomatous lesions of Mycobacterium lepraemurium-induced lepromatoid leprosy in the mouse.
Rojas-Espinosa O; Vega R; Oltra A; Arce P; Nunez A
Int J Lepr Other Mycobact Dis; 1988 Sep; 56(3):428-36. PubMed ID: 3047284
[TBL] [Abstract][Full Text] [Related]
22. Induction of delayed type hypersensitivity against ultrasonicated Mycobacterium lepraemurium bacilli without simultaneous local reactivity against live bacilli or protective immunity.
Løvik M; Closs O
Clin Exp Immunol; 1983 Aug; 53(2):319-27. PubMed ID: 6349877
[TBL] [Abstract][Full Text] [Related]
23. Systemic changes in hydrolytic enzyme activities in mice affected with murine leprosy.
Aoyagi T; Wada T; Kojima F; Nagai M; Yamazaki T; Koseki Y; Umezawa H
Biochem Int; 1985 Jan; 10(1):105-13. PubMed ID: 3885951
[TBL] [Abstract][Full Text] [Related]
24. Experimental murine leprosy. IX. Antibodies against Mycobacterium lepraemurium in C3H and C57BL mice with murine leprosy and in patients with lepromatous leprosy.
Closs O; Kronvall G
Scand J Immunol; 1975; 4(7):735-40. PubMed ID: 1105768
[TBL] [Abstract][Full Text] [Related]
25. Pathogenicity of cultivated murine leprosy bacilli of Hawaiian-Ogawa strain in mice. 3. Transmission of bacilli recovered from subcutaneous leproma induced with smooth-colony variants.
Kawaguchi Y; Matsuoka M; Kawatsu K; Sushida K; Tanemura M
Jpn J Exp Med; 1979 Feb; 49(1):27-32. PubMed ID: 381732
[No Abstract] [Full Text] [Related]
26. Palsy of the rear limbs in Mycobacterium lepraemurium-infected mice results from bone damage and not from nerve involvement.
Rojas-Espinosa O; Becerril-Villanueva E; Wek-Rodríguez K; Arce-Paredes P; Reyes-Maldonado E
Clin Exp Immunol; 2005 Jun; 140(3):436-42. PubMed ID: 15932504
[TBL] [Abstract][Full Text] [Related]
27. Effect of BCG vaccination on Mycobacterium lepraemurium infection in a highly susceptible inbred mouse strain.
Løvik M; Closs O
Acta Pathol Microbiol Scand C; 1981 Apr; 89(2):133-8. PubMed ID: 7027737
[TBL] [Abstract][Full Text] [Related]
28. Inhibition of complement activity in murine leprosy.
Rojas-Espinosa O; Oltra A; Arce P; Mendez P
Int J Lepr Other Mycobact Dis; 1991 Dec; 59(4):605-12. PubMed ID: 1802943
[TBL] [Abstract][Full Text] [Related]
29. Induction of immunity against live Mycobacterium lepraemurium: a requirement for viable bacilli?
Løvik M; Closs O
Immunology; 1984 Sep; 53(1):165-73. PubMed ID: 6381292
[TBL] [Abstract][Full Text] [Related]
30. Induction and treatment of anergy in murine leprosy.
Juarez-Ortega M; Hernandez VG; Arce-Paredes P; Villanueva EB; Aguilar-Santelises M; Rojas-Espinosa O
Int J Exp Pathol; 2015 Feb; 96(1):31-41. PubMed ID: 25529580
[TBL] [Abstract][Full Text] [Related]
31. Experimental murine leprosy. I. Clinical histological evidence for varying susceptibility of mice to infection with Mycobacterium lepraemurium.
Closs O; Haugen OA
Acta Pathol Microbiol Scand A; 1973 Jul; 81(4):401-10. PubMed ID: 4592011
[No Abstract] [Full Text] [Related]
32. Enhancement of resistance in Mycobacterium lepraemurium infected C3H mice by treatment with sonicated M. lepraemurium or splenectomy.
Turcotte R; Chaput J; Lemieux S
Clin Exp Immunol; 1984 Apr; 56(1):97-104. PubMed ID: 6370521
[TBL] [Abstract][Full Text] [Related]
33. The use of the microplate alamar blue assay (MABA) to assess the susceptibility of Mycobacterium lepraemurium to anti-leprosy and other drugs.
Mendoza-Aguilar M; Almaguer-Villagrán L; Jiménez-Arellanes A; Arce-Paredes P; Cid-Gutiérrez JL; Rojas-Espinosa O
J Infect Chemother; 2012 Oct; 18(5):652-61. PubMed ID: 22422299
[TBL] [Abstract][Full Text] [Related]
34. Effect of phorbol myristate acetate, a tumor-promoting agent, on the growth of Mycobacterium lepraemurium in the mouse footpad.
Tomioka H; Saito H
Microbiol Immunol; 1983; 27(5):395-407. PubMed ID: 6353178
[TBL] [Abstract][Full Text] [Related]
35. Activated murine natural killer cells control growth of Mycobacterium lepraemurium in mouse macrophages; in vitro and in vivo evidence.
Denis M
Int J Immunopharmacol; 1991; 13(7):881-7. PubMed ID: 1761354
[TBL] [Abstract][Full Text] [Related]
36. Experimental murine leprosy: a biochemical study emphasizing lysosomal enzyme changes in vivo and enzyme secretion by macrophages in vitro.
Ha DK; Lawton JW; Gardner ID
Exp Mol Pathol; 1984 Apr; 40(2):177-94. PubMed ID: 6368259
[TBL] [Abstract][Full Text] [Related]
37. Recombinant interleukin-1 infusion increases resistance of BALB/c mice to murine leprosy.
Denis M
Int J Immunopharmacol; 1991; 13(7):897-902. PubMed ID: 1761356
[TBL] [Abstract][Full Text] [Related]
38. Propane and tetradecane as carbon sources for in vitro cultivation of Mycobacterium lepraemurium in a liquid medium (a preliminary communication).
Kato L
Acta Microbiol Hung; 1984; 31(4):381-6. PubMed ID: 6399186
[TBL] [Abstract][Full Text] [Related]
39. Experimental murine leprosy. 6. Cellular reactions in the draining lymph node after injection of Mycobacterium lepraemurium into the foot-pads of mice.
Haugen OA; Closs O
Acta Pathol Microbiol Scand A; 1975 Nov; 83(6):683-92. PubMed ID: 1103567
[TBL] [Abstract][Full Text] [Related]
40. Survival of BALB/c mice after intraperitoneal infection with Mycobacterium lepraemurium.
Levy L; Ng H; Welch TM
Isr J Med Sci; 1980 Nov; 16(11):780-4. PubMed ID: 7002862
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
